NEUROMUSCULAR ELECTRICAL STIMULATION FOR THE MANAGEMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE – PILOT STUDY
Objective: The aim of the current research is to evaluate the benefits of electrical stimulation of quadriceps for patients with chronic obstructive pulmonary disease (COPD) patients.
Methods: Ten COPD patients were willing to get enrolled in the study and after baseline screening procedure received neuromuscular electrical stimulation (NMES) with exercises for the bilateral lower limb. NMES is cost-effective and best be available to the population with COPD at the bedside.
Results: There exist a significant increase in five sit to stand test (p<0.01), 6-min walk test (p<0.05), and clinical COPD questionnaire (p<0.05), followed by the application of NMES.
Conclusion: NMES has no impact and stress over the respiratory system and it is a gold standard exercise training modality in improving quality of life and satisfaction for people with COPD in rural locations where access to hospitalization is limited.
2. Sankar UG, Monisha R. Evaluation of cardio-vascular risk in children with developmental coordination disorder in Indian context-pilot study. Res J Pharm Tech 2018;11:5405-7.
3. Sankar UG, Saritha S. A study of the prevalence of developmental coordination disorder (DCD) at Kattankulathur, Chennai. Indian J Physiother Occup Ther 2011;5: ???.
4. Sankar G, Monisha R. Life impact of developmental coordination disorder: Qualitative analysis of patient and therapist experiences. Biomed Pharmacol J 2019;12:491-4.
5. Shankar UG, Monisha R. Assessment of balance in children with developmental coordination disorder in Indian context. Indian J Public Health Res Dev 2019;10:67-70.
6. Monisha R, Manikumar M, Krishnakumar A. Evaluating the effectiveness of phonophoresis by piroxicam and dimethyl sulfoxide for women with osteoarthritis knee joint. Asian J Pharm Clin Res 2018;11:329-31.
7. Solanki ND, Patel A, Patel L. In vitro evaluation of anti-cancer potential of A3 adenosine receptor agonist on a549 human lung cancer cell line. Int J Pharm Pharm Sci 2019;11:106-8.
8. Muhas C, Kumar PR, Raja D. Etiological factors for the development of lung cancer in non-smokers: An overview. Int J Pharm Pharm Sci 2019;11:10-6.
This work is licensed under a Creative Commons Attribution 4.0 International License.
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.